Brain natriuretic peptide and all-cause mortality in patients treated with haemodialysis

Maria K Svensson1,2, Rita Nassar1, Jan Melin1

  • 1Department of Medical Sciences, Renal Medicine, Uppsala University Hospital, Akademiska sjukhuset, Entrance 40, floor 5, Uppsala, SE, 751 85, Sweden.

BMC Nephrology
|June 23, 2025
PubMed

Insights

Brain natriuretic peptide (BNP) correlated with mortality in chronic kidney disease (CKD) patients on hemodialysis. However, age, inflammation, and handgrip strength were more significant predictors of mortality than BNP.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Brain natriuretic peptide (BNP) is a hormone released by the heart in response to fluid overload.
  • In chronic kidney disease (CKD) patients undergoing hemodialysis, fluid overload and overhydration (OH) are significant mortality risks.
  • This study explores the relationship between BNP, OH, and mortality in CKD patients on hemodialysis.

Purpose of the Study:

  • To investigate the association between BNP levels and all-cause mortality in CKD patients on hemodialysis.
  • To determine if overhydration (OH) is a significant factor in mortality for this patient group.
  • To identify key clinical and biochemical predictors of mortality in CKD patients undergoing hemodialysis.

Main Methods:

  • Prospective observational study analyzing five-year survival in 64 CKD patients on hemodialysis.
  • Bivariate correlation analysis to assess relationships between BNP, OH, and all-cause mortality.
  • Cox regression analysis to adjust for clinical and biochemical factors influencing the BNP-mortality relationship.

Main Results:

  • 52% of patients died during the five-year study period.
  • BNP, age, handgrip strength, lean tissue index, and CRP levels were initially associated with all-cause mortality.
  • After adjusting for covariates, age, handgrip strength, and CRP emerged as independent predictors of mortality, while BNP did not.

Conclusions:

  • BNP showed a correlation with all-cause mortality in CKD patients on hemodialysis, but OH did not.
  • Age, inflammation (CRP), and handgrip strength were identified as more significant independent predictors of mortality than BNP.
  • These findings suggest focusing on these clinical factors for risk stratification in CKD patients undergoing hemodialysis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
223
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.2K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
635
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
911
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
215